| Dr Nancy E Waterman, DPM | |
|
694 Main St, East Greenwich, RI 02818-3500 | |
| (401) 884-2821 | |
| (401) 884-4350 |
| Full Name | Dr Nancy E Waterman |
|---|---|
| Gender | Female |
| Speciality | Podiatrist |
| Location | 694 Main St, East Greenwich, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063590941 | NPI | - | NPPES |
| 004282 | Other | RI | BLUE CHIP |
| 9007043 | Medicaid | RI | |
| 7043-2 | Other | RI | BCBS |
| 1104 | Other | RI | NEIGHBORHOOD HEALTH PLANS |
| 480034734 | Other | RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | DPM251 (Rhode Island) | Primary |
| Provider Name | Greenwich Podiatry Group Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285990986 PECOS PAC ID: 7517122484 Enrollment ID: O20120626000611 |
News Archive
Results of recent clinical trials carried out on type 1 diabetics by Nemaura Pharma using its Memspatch Insulin Micro-needle Device (IMD) will come as a relief to those who fear needles and injections, a condition medically known as trypanophobia, affecting 10 percent of the world's population.
As part of its continued effort to give back to the cancer communities in the cities visited during its annual scientific meeting, the Fairfax, Va.-based American Society for Therapeutic Radiology and Oncology (ASTRO) is partnering with the Kenneth B. Schwartz Center to raise awareness of cancer survivorship. The Kenneth B. Schwartz Center conducts pioneering programs to educate, train and support caregivers in the art of compassionate healthcare.
A high-fat diet during pregnancy may program a woman's baby for future diabetes, even if she herself is not obese or diabetic, says a new University of Illinois study published in the Journal of Physiology.
Researchers at the University of British Columbia and the Paul Scherrer Institut in Switzerland have created a microneedle drug monitoring system that could one day replace costly, invasive blood draws and improve patient comfort.
FDA takes an average of seven months to issue warnings to pharmaceutical companies that market medications for off-label uses, and those companies take an average of four months to address the violations, according to a draft report compiled by the Government Accountability Office, the AP/Minneapolis Star Tribune reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy E Waterman, DPM 694 Main St, East Greenwich, RI 02818-3500 Ph: (401) 884-2821 | Dr Nancy E Waterman, DPM 694 Main St, East Greenwich, RI 02818-3500 Ph: (401) 884-2821 |
News Archive
Results of recent clinical trials carried out on type 1 diabetics by Nemaura Pharma using its Memspatch Insulin Micro-needle Device (IMD) will come as a relief to those who fear needles and injections, a condition medically known as trypanophobia, affecting 10 percent of the world's population.
As part of its continued effort to give back to the cancer communities in the cities visited during its annual scientific meeting, the Fairfax, Va.-based American Society for Therapeutic Radiology and Oncology (ASTRO) is partnering with the Kenneth B. Schwartz Center to raise awareness of cancer survivorship. The Kenneth B. Schwartz Center conducts pioneering programs to educate, train and support caregivers in the art of compassionate healthcare.
A high-fat diet during pregnancy may program a woman's baby for future diabetes, even if she herself is not obese or diabetic, says a new University of Illinois study published in the Journal of Physiology.
Researchers at the University of British Columbia and the Paul Scherrer Institut in Switzerland have created a microneedle drug monitoring system that could one day replace costly, invasive blood draws and improve patient comfort.
FDA takes an average of seven months to issue warnings to pharmaceutical companies that market medications for off-label uses, and those companies take an average of four months to address the violations, according to a draft report compiled by the Government Accountability Office, the AP/Minneapolis Star Tribune reports.
› Verified 8 days ago
Andrew J. Lemoi D.p.m., Inc. Podiatrist Medicare: Medicare Enrolled Practice Location: 1050 Main St, Suite 21, East Greenwich, RI 02818 Phone: 401-921-5444 Fax: 401-921-1663 | |
Andrew J Lemoi, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1050 Main St, Ste 21, East Greenwich, RI 02818 Phone: 401-886-1132 Fax: 401-885-6091 | |
Dr. Thomas E Mancini, DPM, FAC, FAS Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1050 Main St, Suite 21, East Greenwich, RI 02818 Phone: 401-885-6090 Fax: 401-885-6091 | |
Greenwich Podiatry Group Podiatrist Medicare: Medicare Enrolled Practice Location: 694 Main St, East Greenwich, RI 02818 Phone: 401-884-2821 Fax: 401-884-4350 | |
Dr. Scott A Handley, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 694 Main St, East Greenwich, RI 02818 Phone: 401-884-2821 | |
Greenwich Podiatry, Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 694 Main St, East Greenwich, RI 02818 Phone: 401-884-2821 Fax: 401-884-4350 |